On ECHEMI
Home > Drugs > Myo-aminoglycan for injection

Myo-aminoglycan for injection

Ingredients

This product contains a variety of cardiovascular active substances, the main components of which include atrial peptides, calcitonin gene-related peptides and nucleotides (nucleosides) such as adenosine triphosphate (adenosine), in addition to more than 20 amino acids and their metabolic intermediates.

Name Description Content CAS NO. Manufacturer
atriopeptin IIIngredients

98084-69-6 0
ADENOSINE 5'-TRIPHOSPHATASEIngredients

9000-83-3 0
AdenosineIngredients

58-61-7 14

Indication

It has the function of promoting the body's metabolism. It is used for muscle atrophy, neurogenic edema, paralysis caused by cerebrovascular accident, neurasthenia syndrome, etc. Ischemic heart and cerebrovascular disease, diabetes, microvascular disease. Congestive heart failure. Various types of hypertension and its complications. Hemiplegia caused by cerebrovascular accident, cerebral arteriosclerosis, muscle atrophy, neurasthenia syndrome. Prevent and treat angina pectoris, myocardial infarction. Toxic and hemorrhagic shock.

Usage and Dosage

Intramuscular injection: 1-2 times a day or as directed by a doctor; intravenous drip: 1-2 times a day, two weeks as a course of treatment

Precautions

It is contraindicated for those who are allergic to any ingredient in this product.

Storage

Sealed, store in a cool dark place

Packaging Specification

Peptide 7.0mg and hypoxanthine 1.0mg

Manufacturer

Ji Lin Jin Sheng Pharmaceutical Co., Ltd.

  • Founded in:

    2014-01-26
  • Address:

    No. 1688, Wutong Road, Meihekou City, Jilin Province
  • Tax NO.:

    91220581088830315W
  • Registered Funds:

    19.5 million yuan
  • Email:

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.